NR4A1 and breast cancer: Strategies for perioperative chemotherapy are established on the basis of the subtypes of BC, namely, hormone receptor (HR)-positive [estrogen receptor (ER) and/or progesterone receptor-positive], human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative.